Company Profile
bioAffinity Technologies, Inc. Stock Price, News & Analysis
- Ticker:
- BIAF
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, bioAffinity Technologies is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
0.84 USD (+4.10%)
Close
Last updated: June 23, 2026 at 00:00
5.3M USD
Market cap
Why the stock is moving
BIAF is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
bioAffinity Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, bioAffinity Technologies is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
bioAffinity Technologies follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, bioAffinity Technologies sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
bioAffinity Technologies Announces Closing of $3.2 Million Offering
Source: bioAffinity Technologies, Inc.
- 03
bioAffinity Technologies Announces Pricing of $3.2 Million Offering
Source: bioAffinity Technologies, Inc.
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of bioAffinity Technologies, Inc. (BIAF)?
bioAffinity Technologies, Inc. (BIAF) most recently closed at 0.84 USD, a +4.10% move versus the previous session.
What is the market cap of bioAffinity Technologies, Inc. (BIAF)?
bioAffinity Technologies, Inc. currently has a market capitalization of 5.3M USD on BioPharmSignal.
What does bioAffinity Technologies, Inc. do?
bioAffinity Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is BIAF stock listed?
bioAffinity Technologies, Inc. (BIAF) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, bioAffinity Technologies is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Technologies?
bioAffinity Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is bioAffinity Technologies, Inc. targeting with Technologies?
bioAffinity Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.